4//SEC Filing
BRUNK GERALD A 4
Accession 0000929638-25-002248
CIK 0001980845other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:37 PM ET
Size
5.8 KB
Accession
0000929638-25-002248
Insider Transaction Report
Form 4
BRUNK GERALD A
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-16+22,500→ 22,500 totalExercise: $3.31Exp: 2035-06-16→ Common Shares (22,500 underlying)
Footnotes (2)
- [F1]This option fully vests on the earlier of (i) the first anniversary of the date vesting commenced, which was June 10, 2025; or (ii) the 2026 Annual Meeting of Shareholders.
- [F2]These options are held of record by Mr. Brunk for the benefit of Lumira Ventures III, L.P. ("Lumira III"), Lumira Ventures III (International), L.P. ("Lumira III Int'l"), Lumira Ventures IV, L.P. ("Lumira IV"), Lumira Ventures IV (International), L.P. ("Lumira IV Int'l"), Merck Lumira Biosciences Fund, L.P. ("Merck-Lumira"), Merck Lumira Biosciences Fund (Quebec), L.P. ("Merck-Lumira B" and, together with Lumira III, Lumira III Int'l, Lumira IV, Lumira IV Int'l, and Merck-Lumira, the "Lumira Entities"). Mr. Brunk expressly disclaims beneficial ownership of these securities.
Documents
Issuer
enGene Holdings Inc.
CIK 0001980845
Entity typeother
Related Parties
1- filerCIK 0001380226
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:37 PM ET
- Size
- 5.8 KB